thymidine has been researched along with Hematologic Malignancies in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate the efficacy of five oral nucleos(t)ide analogues (NAs), including lamivudine, entecavir, adefovir, telbivudine and tenofovir, for the prevention of hepatitis B virus (HBV) reactivation and HBV-related complications in chronic hepatitis B virus (CHB) infected patients with hematological malignancies receiving chemotherapy or hematopoietic stem cell transplantation (HSCT) by network meta-analysis." | 4.95 | Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis. ( Chen, FY; Cheng, Z; Huang, HH; Shi, KQ; Van Poucke, S; Zhang, MY; Zheng, JN; Zheng, MH; Zhu, GQ, 2017) |
| "However, in the case of breast and prostate cancer sera, TK 210 ELISA had higher sensitivity (59% and 44%) compared to [3H]-dThd phosphorylation assay (47% and 25%) at a specificity of 98%." | 1.72 | Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples. ( J, O; Jagarlamudi, KK; L, S; M, Z; P, V; S, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jagarlamudi, KK | 1 |
| L, S | 1 |
| M, Z | 1 |
| J, O | 1 |
| P, V | 1 |
| S, E | 1 |
| Zhang, MY | 1 |
| Zhu, GQ | 1 |
| Zheng, JN | 1 |
| Cheng, Z | 1 |
| Van Poucke, S | 1 |
| Shi, KQ | 1 |
| Huang, HH | 1 |
| Chen, FY | 1 |
| Zheng, MH | 1 |
| Ayres, FM | 1 |
| Narita, M | 1 |
| Takahashi, M | 1 |
| Alldawi, L | 1 |
| Liu, A | 1 |
| Osman, Y | 1 |
| Abe, T | 1 |
| Yano, T | 1 |
| Sakaue, M | 1 |
| Toba, K | 1 |
| Furukawa, T | 1 |
| Aizawa, Y | 1 |
1 review available for thymidine and Hematologic Malignancies
| Article | Year |
|---|---|
Nucleos(t)ide analogues for preventing HBV reactivation in immunosuppressed patients with hematological malignancies: a network meta-analysis.
Topics: Adenine; Antiviral Agents; Controlled Clinical Trials as Topic; Guanine; Hematologic Neoplasms; Hepa | 2017 |
2 other studies available for thymidine and Hematologic Malignancies
| Article | Year |
|---|---|
Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Breast Neoplasms; DNA; Enzyme-Linked Immunosorbent Assay; | 2022 |
A comparative study of the JAM test and 51Cr-release assay to assess the cytotoxicity of dendritic cells on hematopoietic tumor cells.
Topics: Antigens, CD; Cell Death; Cell Differentiation; Cell Division; Cell Line, Tumor; Chromates; Chromium | 2003 |